3 employees
Resilient Lifescience develops a wearable medical device to prevent opioid overdose deaths using naloxone.
2022
$500K
from 2 investors over 2 rounds
Resilient Lifescience raised $500K on February 7, 2023
Investors: Richard King Mellon Foundation
Resilient Lifescience raised $75K on May 17, 2022
Investors: Tau Ventures